Mark A. Nottoli

PharmaNutrients, Inc. researches and develops fatty acids and soluble fiber. The firm provides solutions for obesity-related health issues including weight management, inflammation, diabetes and cardiovascular health. It also provides human-study validated, nutritional bioactive ingredients and technologies to the nutrients, food and pharmaceutical industries. The company was founded by Mark A. Nottoli in 1994 and is headquartered in Lake Forest, IL.

CB4 LLC engages in the development of artificial intelligence tools that helps retailers to fix the costliest execution problems in stores. The company is headquartered in Boulder, CO.

CB5 LLC provides information technology services. The company is headquartered in Boulder, CO.

CanopyCentral LLC (CanopyCentral) is a venture capital firm founded in 2014 by Patrick Rea and Mark Nottoli. The firm is headquartered in Boulder, Colorado.

Wellements LLC manufactures and markets baby products. Its products include organic probotic gripe water, organic gripe water, baby move, baby tooth oil, shampoo & wash and conditioner & detangler. The company was founded by Keyvan Taher in 1984 and headquartered in Scottsdale, AZ.

Bearbull (Belgium) SA is a wholly-owned subsidiary of Banque Degroof, an independent partner-owned bank. Located in Brussels, the firm was established in 1976 and acquired in 2000. The firm provides asset management services to private and institutional clients. The Bearbull family of funds is managed and administered collectively by Bearbull (Belgium) and other Bearbull management teams within the parent group, as well as other asset management teams within Banque Degroof, in particular Degroof Gestion Institutionelle (Luxembourg-based DGI). The Bearbull products are umbrella funds domiciled in Luxembourg or Ireland.

NanoMedex Pharmaceuticals, Inc. develops formulation strategy to allow drugs that are only soluble in oil to be soluble in water. It offers offers Microfol, a micro emulsion formulation containing the generic active pharmaceutical ingredient propofol and two IIG listed excipients-sodium caprylate and poloxamer, which replaces the macro emulsion components of the reference listed drug and its generic equivalents. The company’s formulation is applied to drug classes, including chemotherapeutics, anesthetics, anti-infective, anti-inflammatories and arrythmics, immunosuppressants, and vitamins. NanoMedex Pharmaceuticals was founded by Donn M. Dennis, Nikolaus Gravenstein, Jerome H. Modell and Timothy E. Morey in 2002 and is headquartered in Middleton, WI.